Search results for: 'drug paas'
- Related search terms
- drug 01 00 00 00
- drug discovery ad earth development outsourcing market
- drug discovery ad east development outsourcing market
- paas solutions in the global hydrogen production market
- paas marine industry market
-
22 Jan 2015  |  North America  |  Market Research
A Product and Pipeline Analysis of the Antibacterial Drugs Market
Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...
$3,950.00
Special Price $2,962.50 save 25 %
-
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %
-
02 May 2018  |  North America  |  Market Research
Latin American Software- and Platform-as-a-Service Market, Forecast to 2022
Brazil and Mexico are Leading the Market, Forecast to Reach $6.19 Billion in 2022
The cloud services market in Latin America has been witnessing changes in the consumer mindset toward cloud computing. Companies of different sizes and across a variety of verticals are increasingly understanding the benefits of the SaaS and PaaS solutions and therefore are making investments in the cloud. The SaaS market has diversified industry...
$1,500.00
Special Price $1,125.00 save 25 %
-
13 Oct 2015  |  North America  |  Strategic Forecasting
Why Platform as a Service (PaaS) Will Rule the Cloud
In this analysis, Stratecast provides an overview of the PaaS landscape. We look at the various manifestations of Platform as a Servicepublic and private, open and proprietary, domain-specific and general. We examine the value of PaaS to developers, and what shapes their choices across PaaS providers, including pricing, functionality, and deployme...
$3,950.00
Special Price $2,962.50 save 25 %
-
11 Nov 2016  |  North America  |  Market Research
Global Orphan Drug Market
High Pricing and Undefined Reimbursement Policies will Limit the Sales of Orphan Drugs
The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...
$6,000.00
Special Price $4,500.00 save 25 %
-
29 Dec 2017  |  North America  |  Technology Research
Innovations in Transdermal Drug Delivery
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2020  |  North America  |  Market Research
New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025
AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities
Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 May 2013  |  North America  |  Market Research
Analysis of the North American Oral Solid Drug Dosage Excipients Market
Blockbuster Drug Patent Expiration Expected to Boost Market Growth
Excipients are used to support the delivery of the APIs (active pharmaceutical ingredients) through oral dosage, parenteral, and transdermal medications. For oral dosages, the key delivery forms are tablets and capsules. This research service covers the North American oral solid drug dosage excipients market. Based on functionality, excipients are ...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Dec 2023  |  North America  |  Frost Radar
Frost Radar™: Infrastructure and Platforms as a Service, 2023
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The infrastructure as a service and platform as a service (IaaS and PaaS) industry has undergone a significant evolution in the past year. Macroeconomic instability has negatively affected IT investments and cloud spend, ushering in a growing focus on cloud cost optimization. In tandem, the arrival of generative AI (GenAI) on the scene has necessit...
$4,950.00
Special Price $3,712.50 save 25 %